Equifax Inc. Peer Comparison
| Metric | Value | Ranking | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $30.4 Billion | 2/12 | VRSK $41.0B |
EFX $30.4B |
TRU $16.5B |
BAH $13.4B |
FCN $5.9B |
EXPO $4.2B |
HURN $2.5B |
ICFI $1.6B |
CRAI $1.2B |
FC $370.8M |
RGP $223.4M |
FORR $181.4M |
| Gross Margin | 100% | 1/12 | EFX 100% |
HURN 100% |
FC 76% |
VRSK 69% |
TRU 60% |
FORR 59% |
BAH 55% |
RGP 39% |
ICFI 36% |
CRAI 32% |
FCN 30% |
EXPO 0% |
| Profit Margin | 12% | 2/12 | VRSK 29% |
EFX 12% |
HURN 9% |
CRAI 8% |
BAH 6% |
TRU 6% |
FCN 6% |
ICFI 5% |
FC 2% |
EXPO 0% |
FORR 0% |
RGP -47% |
| EBITDA margin | 32% | 1/12 | EFX 32% |
TRU 29% |
VRSK 22% |
CRAI 13% |
HURN 12% |
ICFI 10% |
BAH 8% |
FCN 8% |
FORR 7% |
FC 6% |
RGP -54% |
EXPO -100% |
| Quarterly Revenue | $1.4 Billion | 2/12 | BAH $2.9B |
EFX $1.4B |
TRU $1.0B |
FCN $894.9M |
VRSK $735.6M |
ICFI $496.3M |
HURN $399.3M |
CRAI $176.4M |
RGP $145.6M |
FORR $108.0M |
FC $69.1M |
EXPO $0 |
| Quarterly Earnings | $174.0 Million | 3/12 | VRSK $210.4M |
BAH $187.0M |
EFX $174.0M |
TRU $66.2M |
FCN $49.7M |
HURN $34.0M |
ICFI $24.6M |
EXPO $23.6M |
CRAI $15.0M |
FC $1.2M |
FORR $432,000 |
RGP -$68.7M |
| Quarterly Free Cash Flow | $205.9 Million | 2/12 | FCN $301.6M |
EFX $205.9M |
TRU $136.9M |
BAH $133.6M |
HURN $132.4M |
ICFI $89.5M |
CRAI $68.8M |
FC $13.1M |
RGP $61,000 |
VRSK -$0 |
FORR -$2.5M |
EXPO -$0 |
| Trailing 4 Quarters Revenue | $5.7 Billion | 2/12 | BAH $11.8B |
EFX $5.7B |
TRU $4.2B |
FCN $3.7B |
VRSK $2.9B |
ICFI $2.0B |
HURN $1.5B |
CRAI $687.4M |
RGP $582.1M |
FORR $432.5M |
EXPO $421.7M |
FC $287.9M |
| Trailing 4 Quarters Earnings | $707.7 Million | 3/12 | BAH $2.9B |
EFX $1.4B |
TRU $1.0B |
FCN $894.9M |
VRSK $735.6M |
ICFI $496.3M |
HURN $399.3M |
CRAI $176.4M |
RGP $145.6M |
FORR $108.0M |
FC $69.1M |
EXPO -$0 |
| Quarterly Earnings Growth | 31% | 4/12 | HURN 1100% |
TRU 412% |
FORR 165% |
EFX 31% |
CRAI 31% |
BAH 28% |
VRSK 21% |
EXPO 13% |
ICFI 11% |
FCN -39% |
FC -76% |
RGP -1504% |
| Annual Earnings Growth | 14% | 9/12 | TRU 123% |
HURN 73% |
BAH 32% |
VRSK 30% |
FC 26% |
CRAI 25% |
ICFI 18% |
EXPO 15% |
EFX 14% |
FCN -16% |
FORR -185% |
RGP -531% |
| Quarterly Revenue Growth | 7% | 6/12 | BAH 14% |
HURN 14% |
TRU 9% |
VRSK 9% |
CRAI 9% |
EFX 7% |
ICFI 4% |
FC 1% |
FCN -3% |
FORR -9% |
RGP -11% |
EXPO -100% |
| Annual Revenue Growth | 8% | 3/12 | CRAI 14% |
BAH 11% |
EFX 8% |
TRU 8% |
VRSK 6% |
HURN 5% |
FCN 3% |
ICFI 2% |
FC -5% |
FORR -6% |
RGP -14% |
EXPO -34% |
| Cash On Hand | $169.9 Million | 6/12 | VRSK $1.1B |
TRU $679.5M |
FCN $660.5M |
BAH $453.5M |
EXPO $258.9M |
EFX $169.9M |
RGP $78.2M |
FORR $56.1M |
FC $53.3M |
CRAI $26.7M |
HURN $21.9M |
ICFI $5.0M |
| Short Term Debt | $687.7 Million | 1/12 | EFX $687.7M |
BAH $123.4M |
TRU $92.6M |
HURN $38.4M |
FCN $34.1M |
ICFI $23.3M |
FORR $12.8M |
RGP $10.8M |
EXPO $5.4M |
FC $835,000 |
VRSK -$0 |
CRAI -$0 |
| Long Term Debt | $4.3 Billion | 2/12 | TRU $5.1B |
EFX $4.3B |
ICFI $578.9M |
FCN $208.0M |
BAH $181.7M |
CRAI $84.5M |
EXPO $76.1M |
FORR $59.8M |
RGP $44.7M |
HURN $29.7M |
FC $2.1M |
VRSK $0 |
| PE | 42.99 | 2/12 | TRU 58.11 |
EFX 42.99 |
VRSK 42.76 |
EXPO 38.25 |
CRAI 25.65 |
HURN 21.63 |
FCN 20.95 |
BAH 15.44 |
ICFI 14.39 |
FC 11.66 |
FORR -1.00 |
RGP -1.00 |
| PS | 5.36 | 3/12 | VRSK 14.22 |
EXPO 9.89 |
EFX 5.36 |
TRU 3.95 |
CRAI 1.74 |
HURN 1.66 |
FCN 1.59 |
FC 1.29 |
BAH 1.14 |
ICFI 0.78 |
FORR 0.42 |
RGP 0.38 |
| PB | 6.18 | 4/12 | VRSK 30.07 |
BAH 11.08 |
EXPO 9.90 |
EFX 6.18 |
CRAI 5.64 |
FC 4.60 |
HURN 4.49 |
TRU 3.83 |
FCN 2.60 |
ICFI 1.61 |
FORR 0.79 |
RGP 0.69 |
| PC | 179.09 | 2/12 | ICFI 319.62 |
EFX 179.09 |
HURN 115.14 |
CRAI 44.78 |
VRSK 35.81 |
BAH 29.56 |
TRU 24.31 |
EXPO 16.10 |
FCN 8.88 |
FC 6.96 |
FORR 3.23 |
RGP 2.86 |
| Liabilities to Equity | 1.43 | 5/12 | BAH 4.64 |
FC 1.97 |
CRAI 1.69 |
TRU 1.58 |
EFX 1.43 |
HURN 1.39 |
FORR 1.20 |
ICFI 1.10 |
EXPO 0.85 |
FCN 0.59 |
RGP 0.30 |
VRSK 0.00 |
| ROA | 0.06 | 8/12 | VRSK 70% | EXPO 14% | BAH 13% | FC 13% | HURN 9% | CRAI 8% | FCN 8% | EFX 6% | ICFI 5% | TRU 3% | FORR -1% | RGP -14% |
| ROE | 0.15 | 6/12 | BAH 72% |
FC 39% |
EXPO 26% |
CRAI 22% |
HURN 21% |
EFX 15% |
FCN 12% |
ICFI 11% |
TRU 7% |
FORR -3% |
RGP -19% |
VRSK -100% |
| Current Ratio | 1.72 | 6/12 | RGP 4.28 |
FCN 2.69 |
EXPO 2.18 |
ICFI 1.91 |
FORR 1.84 |
EFX 1.72 |
HURN 1.72 |
TRU 1.65 |
CRAI 1.59 |
FC 1.51 |
BAH 1.22 |
VRSK -1.00 |
| Quick Ratio | 0.02 | 10/12 | TRU 58.11 |
EFX 42.99 |
VRSK 42.76 |
EXPO 38.25 |
CRAI 25.65 |
HURN 21.63 |
FCN 20.95 |
BAH 15.44 |
ICFI 14.39 |
FC 11.66 |
FORR -1.00 |
RGP -1.00 |
| Long Term Debt to Equity | 0.90 | 2/12 | TRU} 1.21 |
EFX} 0.90 |
ICFI} 0.59 |
CRAI} 0.40 |
FORR} 0.26 |
EXPO} 0.18 |
BAH} 0.15 |
RGP} 0.14 |
FCN} 0.09 |
HURN} 0.05 |
FC} 0.03 |
VRSK} -1.00 |
| Debt to Equity | 1.04 | 2/12 | TRU 1.24 |
EFX 1.04 |
ICFI 0.61 |
CRAI 0.40 |
FORR 0.32 |
BAH 0.25 |
EXPO 0.19 |
FCN 0.11 |
HURN 0.10 |
RGP 0.09 |
FC 0.02 |
VRSK -1.00 |
| Burn Rate | 0.99 | 5/12 | FORR 10.89 |
TRU 4.20 |
ICFI 1.12 |
RGP 1.07 |
EFX 0.99 |
HURN -0.94 |
CRAI -2.30 |
BAH -3.05 |
VRSK -5.44 |
EXPO -13.49 |
FCN -20.10 |
FC -60.00 |
| Cash to Cap | 0.01 | 10/12 | RGP 0.35 |
FORR 0.31 |
FC 0.14 |
FCN 0.11 |
EXPO 0.06 |
TRU 0.04 |
BAH 0.03 |
VRSK 0.03 |
CRAI 0.02 |
EFX 0.01 |
HURN 0.01 |
ICFI 0.00 |
| CCR | 1.18 | 7/12 | FC 11.13 |
FCN 6.07 |
CRAI 4.59 |
HURN 3.90 |
ICFI 3.64 |
TRU 2.07 |
EFX 1.18 |
BAH 0.71 |
VRSK 0.00 |
RGP 0.00 |
FORR -5.76 |
EXPO |
| EV to EBITDA | 77.51 | 4/12 | VRSK} 243.70 |
EXPO} 146.47 |
FC} 80.28 |
EFX} 77.51 |
FCN} 74.36 |
TRU} 70.20 |
BAH} 54.58 |
HURN} 53.46 |
CRAI} 52.80 |
ICFI} 42.96 |
FORR} 26.09 |
RGP} -2.20 |
| EV to Revenue | 6.21 | 3/12 | VRSK 13.82 |
EXPO 9.46 |
EFX 6.21 |
TRU 5.03 |
CRAI 1.82 |
HURN 1.68 |
FCN 1.47 |
BAH 1.13 |
FC 1.11 |
ICFI 1.08 |
FORR 0.46 |
RGP 0.30 |